aluminum phosphate has been researched along with Grippe in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (42.86) | 29.6817 |
2010's | 3 (42.86) | 24.3611 |
2020's | 1 (14.29) | 2.80 |
Authors | Studies |
---|---|
Balaton, G; Torzsa, P; Vajo, P; Vajo, Z | 1 |
Babecoff, R; Ben-Yedidia, T; Bruzil, S; Lowell, GH; Ziv, S | 1 |
Fazekas, G; Jankovics, I; Martosne-Mendi, R; Szilvasy, I; Vajo, Z | 1 |
Vajo, Z | 1 |
Bartha, K; Jankovics, I; Jankovics, M; Kis, A; Kosa, L; Pauliny, Z; Szilvasy, I; Vajo, Z; Visontay, I | 1 |
Brown, LE | 1 |
Chang, SC; Chong, P; Chou, AH; Dong, SX; Hsieh, SM; Hu, MH; Kao, TM; Kung, HC; Pan, SC; Wu, H | 1 |
2 review(s) available for aluminum phosphate and Grippe
Article | Year |
---|---|
Influenza A (H5N1) pandemic prototype vaccine Fluval.
Topics: Adjuvants, Immunologic; Aluminum Compounds; Disease Outbreaks; Humans; Hungary; Influenza A Virus, H5N1 Subtype; Influenza Vaccines; Influenza, Human; Phosphates; Vaccines, Inactivated | 2009 |
The role of adjuvants in vaccines for seasonal and pandemic influenza.
Topics: Adjuvants, Immunologic; Aluminum Compounds; Animals; Cholesterol; Drug Combinations; Humans; Influenza Vaccines; Influenza, Human; Mice; Phosphates; Phospholipids; Saponins | 2010 |
4 trial(s) available for aluminum phosphate and Grippe
Article | Year |
---|---|
A Reduced Dose Whole Virion Aluminum Adjuvanted Seasonal Influenza Vaccine Is Immunogenic, Safe, and Well Tolerated in Pediatric Patients.
Topics: Adjuvants, Immunologic; Adolescent; Aluminum Compounds; Child; Child, Preschool; Female; Humans; Hungary; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H3N2 Subtype; Influenza B virus; Influenza Vaccines; Influenza, Human; Male; Phosphates; Prospective Studies; Virion | 2021 |
Back to the future: Immunization with M-001 prior to trivalent influenza vaccine in 2011/12 enhanced protective immune responses against 2014/15 epidemic strain.
Topics: Adjuvants, Immunologic; Aged; Aged, 80 and over; Aluminum Compounds; Antibodies, Neutralizing; Antibodies, Viral; Cross Protection; Female; Hemagglutination Inhibition Tests; Humans; Immunization; Immunization Schedule; Immunogenicity, Vaccine; Influenza A Virus, H3N2 Subtype; Influenza Vaccines; Influenza, Human; Male; Phosphates; T-Lymphocytes; Vaccines, Subunit | 2017 |
Yearly licensing studies from 1997 to 2007 of the inactivated whole virus seasonal influenza vaccine fluval--a useful approach to pandemic vaccine development even in less well developed countries?
Topics: Adjuvants, Immunologic; Adolescent; Adult; Aged; Aged, 80 and over; Aluminum Compounds; Antibodies, Viral; Drug Approval; Female; Hemagglutination Inhibition Tests; Humans; Influenza A Virus, H5N1 Subtype; Influenza Vaccines; Influenza, Human; Male; Middle Aged; Phosphates; Vaccines, Inactivated; Young Adult | 2008 |
The Madin-Darby canine kidney cell culture derived influenza A/H5N1 vaccine: a phase I trial in Taiwan.
Topics: Adjuvants, Immunologic; Adult; Aluminum Compounds; Animals; Antibodies, Neutralizing; Antibodies, Viral; Dogs; Drug-Related Side Effects and Adverse Reactions; Female; Healthy Volunteers; Hemagglutination Inhibition Tests; Humans; Influenza A Virus, H5N1 Subtype; Influenza Vaccines; Influenza, Human; Injections, Intramuscular; Madin Darby Canine Kidney Cells; Male; Middle Aged; Neutralization Tests; Phosphates; Prospective Studies; Single-Blind Method; Taiwan; Vaccination; Vaccines, Inactivated; Virus Cultivation; Young Adult | 2013 |
1 other study(ies) available for aluminum phosphate and Grippe
Article | Year |
---|---|
Cross-reactive immunity to clade 2 strains of influenza virus A subtype H5N1 induced in adults and elderly patients by Fluval, a prototype pandemic influenza virus vaccine derived by reverse genetics, formulated with a phosphate adjuvant, and directed to
Topics: Adjuvants, Immunologic; Adult; Aged; Aged, 80 and over; Aluminum Compounds; Antibodies, Viral; Disease Outbreaks; Female; Hemagglutination Inhibition Tests; Hemagglutinins, Viral; Humans; Influenza A Virus, H5N1 Subtype; Influenza Vaccines; Influenza, Human; Male; Middle Aged; Phosphates; Phylogeny; Young Adult | 2009 |